Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Joint Bone Spine

Topics

Medicine

Immunology

Dermatology

Internal Medicine

Rheumatology

Show all topics

DOI

10.1016/j.jbspin.2024.105824

License

CC-BY